Sudeep Pharma Limited held an earnings conference call to discuss its Q1 FY27 financial and operational performance.

Management provided insights into business drivers, strategic growth initiatives, and the outlook for the remainder of the fiscal year.

The discussion also covered operational updates and addressed analyst questions regarding segment performance and future capacity expansions.